|
|
|
By Tiffany Lucas, Ph.D. and Ifty Saiyed, Eliquent Life Sciences | The U.K.'s MHRA has released a new draft guideline outlining best practices for drug product design, CMC, and manufacturing of mRNA cancer immunotherapies using LNP delivery systems. The public comment period ends March 31. | |
|
|
|
|
|
| Navigating Cell Therapy Process Development | e-book | Cytiva | Equip yourself with the knowledge necessary to make well-informed decisions by exploring the main challenges and considerations inherent in cell therapy process development. |
|
|
| Enabled Form Selection For Oral Drug Products | Webinar | Lonza | Review the role of solid form screening and PBPK modeling to enable accelerated timelines desirable in early-phase drug development. Explore formulation maps for ASDs and key criteria for salt screening. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|